Abstract. Traditional neuroimaging studies in Alzheimer’s disease (AD) typically employ independent and pairwise analyses between multimodal data, which treat imaging biomarkers, cognitive measures, and disease status as isolated units. To enhance mechanistic understanding of AD, in this paper, we conduct a new study for identifying imaging biomarkers that are associated with both cognitive measures and AD. To achieve this goal, we propose a new sparse joint classification and regression method. The imaging biomarkers identified by our method are AD-sensitive and cognition-relevant and can help reveal complex relationships among brain structure, cognition and disease status. Using the imaging and cognition data from Alzheimer’s Disease Neur...
Brain aging is a multifaceted process that remains poorly understood. Despite significant advances i...
A neuroimaging feature extraction model is designed to extract region-based image features whose val...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by memory loss and declined co...
MotivationRecent advances in brain imaging and high-throughput genotyping techniques enable new appr...
Motivation: Recent advances in brain imaging and high-throughput genotyping techniques enable new ap...
Alzheimer’s disease (AD) is the most common form of de-mentia that causes progressive impairment of ...
Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of ...
Alzheimer’s disease (AD) is characterized by an accumulation of abnormal plaques and tangles in the ...
Recent changes in diagnostic criteria for Alzheimer’s disease (AD) state that biomarkers can enhance...
Alzheimer\u27s Disease consists of a complex cascade of pathological processes, leading to the death...
The early diagnosis of Alzheimer's disease (AD) and mild cognitive impairment (MCI) is very importan...
Biomarkers derived from brain magnetic resonance imaging have promise in being able to assist in the...
Predicting cognitive performance of subjects from their magnetic resonance imaging (MRI) measures an...
Abstract: Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the ...
poster abstractRegression models have been widely studied to investigate whether multimodal neuroima...
Brain aging is a multifaceted process that remains poorly understood. Despite significant advances i...
A neuroimaging feature extraction model is designed to extract region-based image features whose val...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by memory loss and declined co...
MotivationRecent advances in brain imaging and high-throughput genotyping techniques enable new appr...
Motivation: Recent advances in brain imaging and high-throughput genotyping techniques enable new ap...
Alzheimer’s disease (AD) is the most common form of de-mentia that causes progressive impairment of ...
Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of ...
Alzheimer’s disease (AD) is characterized by an accumulation of abnormal plaques and tangles in the ...
Recent changes in diagnostic criteria for Alzheimer’s disease (AD) state that biomarkers can enhance...
Alzheimer\u27s Disease consists of a complex cascade of pathological processes, leading to the death...
The early diagnosis of Alzheimer's disease (AD) and mild cognitive impairment (MCI) is very importan...
Biomarkers derived from brain magnetic resonance imaging have promise in being able to assist in the...
Predicting cognitive performance of subjects from their magnetic resonance imaging (MRI) measures an...
Abstract: Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the ...
poster abstractRegression models have been widely studied to investigate whether multimodal neuroima...
Brain aging is a multifaceted process that remains poorly understood. Despite significant advances i...
A neuroimaging feature extraction model is designed to extract region-based image features whose val...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by memory loss and declined co...